Bishop John E — SEC Form 4 filings

SEC reporting owner CIK 1308911. 5 Form 4 filings on record with FilingPulse; latest filed 2026-08-25.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-02-01 to 2026-08-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ARDELYX, INC. (ARDX)See Remarks46 legs · 25,235 sh · $109,2132
Lyra Therapeutics, Inc. (LYRA)Chief Technology Officer11

Form 4 filings — Bishop John E

FiledFormIssuerReported transactionsSource
2026-08-254ARDELYX, INC. (ARDX)Sale (S): 17,281 @ $3.86 · Sale (S): 2,469 @ $3.86EDGAR
2026-05-224ARDELYX, INC. (ARDX)Sale (S): 2,306 @ $6.27EDGAR
2026-02-234ARDELYX, INC. (ARDX)Sale (S): 2,792 @ $5.87 · Sale (S): 386 @ $5.71 · Sale (S): 1 @ $5.70EDGAR
2026-01-264ARDELYX, INC. (ARDX)Grant/award (A): 124,330 @ $0 · Grant/award (A): 186,500 (derivative) @ $0EDGAR
2024-02-014Lyra Therapeutics, Inc. (LYRA)Grant/award (A): 200,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1308911 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →